Pasadena & Claremont Attorney: Scott Glovsky
Were you denied SPINRAZA by Anthem or another health insurance company?
SPINRAZA is the first treatment approved by the FDA to treat Spinal Muscular Attrophy (“SMA”) in both infants and adults. SMA is the most common cause of mortality in infants linked to a genetic mutation. It affects between 1 in 6,000 and 1 in 10,000 people. According to Biogen, the manufacturer of SPINRAZA, “individuals with infantile-onset SMA treated with SPINRAZA achieved and sustained clinically meaningful improvements in motor function compared to untreated individuals. In addition to the controlled clinical study in individuals with infantile-onset SMA, the efficacy of SPINRAZA was supported by open-label uncontrolled studies in symptomatic individuals who ranged in age from approximately 1 month to 15 years, as well as presymptomatic individuals who ranged in age from approximately 8 to 42 days at the time of first dose.” SPINRAZA appears to be the wonder drug many SMA patients have dreamed about.
But many insurance providers deny SPRINAZA because it is expensive. Have you been denied SPINRAZA by:
- Anthem Blue Cross,
- Kaiser,
- Blue Shield,
- Health Net,
- UnitedHealthcare,
- Aetna, or
- another insurance company?
The Law Offices of Scott Glovsky may be able to help you seek justice.
Can the Law Offices of Scott Glovsky help you?
Los Angeles, Claremont, and Pasadena SPINRAZA denial attorney Scott Glovsky helps members seek just for medical necessity denials. Please call our office at (626) 604-6973 or click here for a free consultation.
